Eli Lilly and Company

Alternance 12 mois – Apprenti(e) Solutions Marketing B2B et stratégie commerciale Obésité – F/H

Neuilly-sur-Seine, Ile-de-France, France

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
InternshipJob Type
UnknownVisa
Pharmaceuticals, MarketingIndustries

Requirements

The ideal candidate should be a pharmacist with a specialization in business/marketing, and preferably possess prior experience in the pharmaceutical industry or in pharmacies. They should be autonomous, proactive, and rigorous, demonstrating initiative, creativity, analytical skills, and strong interpersonal abilities. Furthermore, they should have a good command of English and proficiency in computer tools, along with a genuine interest in digital technologies.

Responsibilities

As an apprentice, the Solutions Marketing B2B and commercial strategy apprentice will be responsible for developing, designing, and monitoring the deployment of tools and solutions that support the strategy and partnerships with pharmacies, in collaboration with marketing and medical teams. They will also define and develop a mapping of key actors in the product journey (pharmacies, pharmacy groups, central pharmacies, other private structures) to identify priority partnership opportunities, measure and drive the performance and impact of partnership and commercial actions, and participate in tactical and strategic thinking phases on the product and patient care pathway, contributing to their knowledge and understanding of the environment and partners. Finally, they will ensure competitive monitoring.

Skills

Marketing
B2B
Strategic Thinking
Analytical Skills
Interpersonal Skills
English
Digital Technologies
Competitive Monitoring
Pharmacy

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI